| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.66M | 10.53M | 10.86M | 8.62M | 6.43M |
| Gross Profit | 3.80M | 4.65M | 4.81M | 4.99M | 4.08M |
| EBITDA | -4.03M | -2.84M | -3.81M | -3.09M | -2.89M |
| Net Income | -5.14M | -3.86M | -4.82M | -3.65M | -4.20M |
Balance Sheet | |||||
| Total Assets | 11.74M | 12.56M | 16.56M | 21.77M | 17.71M |
| Cash, Cash Equivalents and Short-Term Investments | 4.98M | 2.39M | 5.73M | 11.13M | 7.08M |
| Total Debt | 2.33M | 2.66M | 2.78M | 3.15M | 2.84M |
| Total Liabilities | 4.59M | 5.98M | 5.74M | 5.74M | 7.04M |
| Stockholders Equity | 7.08M | 5.46M | 9.28M | 13.99M | 9.76M |
Cash Flow | |||||
| Free Cash Flow | -2.69M | -3.12M | -4.35M | -4.28M | -4.27M |
| Operating Cash Flow | -2.35M | -2.63M | -3.59M | -3.52M | -4.07M |
| Investing Cash Flow | -1.76M | -438.71K | -1.17M | -1.64M | -837.81K |
| Financing Cash Flow | 6.58M | -278.79K | -430.02K | 8.98M | 1.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | £28.10M | -1.76 | ― | ― | -27.64% | 35.09% | |
53 Neutral | £5.22M | -12.73 | -11.10% | ― | 14.51% | 77.27% | |
50 Neutral | £14.30M | -14.83 | -12.88% | ― | 25.56% | 35.12% | |
45 Neutral | £8.09M | -2.23 | -78.76% | ― | -24.85% | 40.28% | |
39 Underperform | £661.10K | -0.08 | -235.32% | ― | -38.73% | 96.64% | |
31 Underperform | £6.24M | -0.80 | ― | ― | ― | ― |
The recent earnings call for Directa Plus conveyed an optimistic outlook, highlighting notable achievements in revenue growth, cost reduction, and strategic partnerships. Despite these successes, the company faces challenges, including workforce reductions and contract delays.
Directa Plus reported a 15% increase in revenue to €3.90m for the first half of 2025, alongside a significant improvement in EBITDA loss, reflecting strategic focus on high-margin contracts and operational efficiencies. The company is nearing completion of a production system upgrade, expected to enhance scalability and reduce costs, positioning it to capture new market opportunities. With key contract renewals and new project wins, particularly in environmental remediation and textiles, Directa Plus is poised for future growth, although challenges such as competitive contract renewals may impact forecasts.
The most recent analyst rating on (GB:DCTA) stock is a Hold with a £10.00 price target. To see the full list of analyst forecasts on Directa Plus stock, see the GB:DCTA Stock Forecast page.
Directa Plus announced that its CEO, Giulio Cesareo, has acquired 28,600 ordinary shares, increasing his total interest to 4.24% of the company’s voting rights. This transaction underscores Cesareo’s confidence in the company’s future and may positively influence stakeholder perceptions, reinforcing Directa Plus’s position in the graphene industry.
Directa Plus reported a 15% revenue increase to approximately €3.9 million for the first half of 2025, along with a 40% reduction in EBITDA losses, reflecting strategic focus on high-value contracts and operational efficiencies. The company secured significant contract renewals and new agreements, including a major deal with OMV Petrom and a distribution agreement in the U.S. environmental market. Upcoming production upgrades are expected to enhance capabilities and expand market reach, particularly in the nano-graphite sector, supporting further growth and operational reliability.